Medicinal Chemistry Research

, Volume 21, Issue 10, pp 3087–3103

Quantitative structure–activity relationship and design of polysubstituted quinoline derivatives as inhibitors of phosphodiesterase 4

Original Research


2D quantitative structure–activity relationships (2D QSAR) and hologram quantitative structure–activity relationship (HQSAR) studies were performed on a series of polysubstituted quinoline derivatives as inhibitors of phosphodiesterase 4 (PDE4). The dataset was divided into training set and test set by K-means clustering. 2D QSAR study was carried out using stepwise linear regression analysis, replacement method and enhanced replacement method. Statistically significant equations with high correlation coefficient (R2 = 0.817) and low standard deviation (SD = 0.272) were obtained. The robustness of the models was confirmed with the help of leave one out cross validation (Rcv2 = 0.740), Y scrambling (R2 = 0.374), and by predicting the activities of test molecules (Rpred2 = 0.627). A good correlation of topology, steric and polar features of polysubstituted quinoline derivatives with the PDE4 inhibitory activity was achieved. HQSAR calculations were carried out using various combinations of fragment size, hologram length and fragment type. The best HQSAR model was obtained with an R2 value of 0.952 and \( R_{\text{cv}}^{2} \) value of 0.783. The test-set of molecules was predicted by the HQSAR model. The results of 2D QSAR and HQSAR studies were used to design new molecules and to predict their activity using the developed models.


Phosphodiesterase HQSAR QSAR K-means clustering Enhanced replacement method Replacement method 


  1. Caballero J, Fernandez M (2008) Artificial neural networks from MATLAB in medicinal chemistry. Bayesian-regularized genetic neural networks (BRGNN): application to the prediction of the antagonistic activity against human platelet thrombin receptor (PAR-1). Curr Top Med Chem 8:1580–1605PubMedCrossRefGoogle Scholar
  2. Christensen SB, Torphy TJ (1994) Isozyme-selective phosphodiesterase inhibitors as antiasthmatic agents. In: Bristol AJ (ed) Annual reports in medicinal chemistry, vol 29. Academic Press, New York, pp 185–194Google Scholar
  3. Dougherty ER, Barrera J, Brun M, Kim S, Cesar RM, Chen Y, Bittner M, Trent JM (2002) Inference from clustering with application to gene-expression microarrays. J Comput Biol 9:105–126PubMedCrossRefGoogle Scholar
  4. Draper NR, Smith H (1981) Applied regression analysis. Wiley, New YorkGoogle Scholar
  5. Duchowicz PR, Castro EA, Fernández FM (2006a) Inference from clustering with application to gene-expression microarrays. Commun Math Comput Chem 55:179–192Google Scholar
  6. Duchowicz PR, Fernández M, Caballero J, Castro EA, Fernández FM (2006b) QSAR for non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorg Med Chem 14:5876–5889PubMedCrossRefGoogle Scholar
  7. Duchowicz PR, Vitale MG, Castro EA, Fernandez M, Caballero J (2007) QSAR analysis for heterocyclic antifungals. Bioorg Med Chem 15:2680–2689PubMedCrossRefGoogle Scholar
  8. Duchowicz PR, Talevi A, Bruno-Blanch LE, Castro E (2008) A new QSPR study for the prediction of aqueous solubility of drug-like compounds. Bioorg Med Chem 16:7944–7955PubMedCrossRefGoogle Scholar
  9. Duchowicz PR, Goodarzi M, Ocsachoque MA, Romanelli GP, Ortiz EV, Autino JC, Bennardi DO, Ruiz D, Castro EA (2009) QSAR analysis on Spodoptera litura antifeedant activities for flavone derivatives. Sci Total Environ 408:277–285PubMedCrossRefGoogle Scholar
  10. Duplantier AJ, Anderson CJ, Cheng JB, Cohan VL, Decker C, Di Capua FM (1998) 7-Oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridines as novel inhibitors of human eosinophil phosphodiesterase. J Med Chem 41:2268–2277PubMedCrossRefGoogle Scholar
  11. Eriksson L, Jaworska J, Worth AP, Cronin MTD, McDowell RM, Gramatica P (2003) Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSAR. Environ Health Perspect 111:1361–1375PubMedCrossRefGoogle Scholar
  12. Everitt B, Landau S, Leese M (2001) Cluster analysis. Arnold, LondonGoogle Scholar
  13. Francis S, Turko I, Corbin VJD (2000) Cyclic nucleotide phosphodiesterases: relating structure and function. Prog Nucl Acid Res 65:1–52CrossRefGoogle Scholar
  14. Giembycz MA, Dent G (1992) Prospects for selective cyclic nucleotide phosphodiesterase inhibitors in the treatment of bronchial asthma. Clin Exp Allergy 22:337–344PubMedCrossRefGoogle Scholar
  15. Golbraikh A, Tropsha J (2002) Beware of q2! Mol Graph Model 20:269–276CrossRefGoogle Scholar
  16. Goodarzi M, Duchowicz PR, Wu CH, Fernández FM, Castro EA (2009) New hybrid genetic based support vector regression as QSAR approach for analyzing flavonoids-GABA(A) complexes. J Chem Inf Model 49:1475–1485PubMedCrossRefGoogle Scholar
  17. Guha R, Jurs PC (2005) Determining the validity of a QSAR model—a classification approach. J Chem Inf Model 45:65–73PubMedCrossRefGoogle Scholar
  18. Gupta SP, Mathur AN, Naggapa AN, Kumar D, Kumaran S (2003) A quantitative structure-activity relationship study on a novel class of calcium entry blockers:1-[{4-(aminoalkoxy)phenylsulfonyl] indolizines. Eur J Med Chem 38:867–873PubMedCrossRefGoogle Scholar
  19. Helguera AM, Duchowicz PR, Perez MAC, Castro EA, Cordeiro MNDS, González MP (2006) Application of the replacement method as a novel variable selection strategy in QSAR. 1. Carcinogenic potential. Chemom Intell Lab Syst 81:180–187CrossRefGoogle Scholar
  20. Horowski R, Sastre-y-Herandez M (1985) Clinical effects of neurotropic selective cyclic AMP phosphodiesterase inhibitor rolipram in depressed patients: global evaluation of the preliminary reports. Curr Ther Res 38:23–29Google Scholar
  21. HQSAR manual SYBYL-X 1.2. Tripos, St. LouisGoogle Scholar
  22. Kammer GM (1988) The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol Today 9:222–229PubMedCrossRefGoogle Scholar
  23. Leardi R, Gonzalez LA (1998) Genetic algorithms applied to feature selection in PLS regression: how and when to use them. Chemom Intell Lab Syst 41:195–207CrossRefGoogle Scholar
  24. Leonard JT, Roy K (2006) On selection of training and test sets for the development of predictive QSAR models. QSAR Comb Sci 25:235–251CrossRefGoogle Scholar
  25. Lunniss CJ, Cooper AW, Eldred CD, Kranz M, Lindvall M, Lucas FS, Neu M, Preston AG, Ranshaw LE, Redgrave AJ, Robinson J, Shipley TJ, Solanke YE, Somers DO, Wiseman JO (2009) Quinolines as a novel structural class of potent and selective PDE4 inhibitors: optimisation for oral administration. Bioorg Med Chem Lett 19:1380–1385PubMedCrossRefGoogle Scholar
  26. Mercader AG, Duchowicz PR, Ferna′ndez FM, Castro EA, Bennardi DO, Autino JC, Romanelli GP (2008a) QSAR prediction of inhibition of aldose reductase for flavonoids. Bioorg Med Chem 16:7470–7476PubMedCrossRefGoogle Scholar
  27. Mercader AG, Duchowicz PR, Fernandez FM, Castro EA (2008b) Modified and enhanced replacement method for the selection of molecular descriptors in QSAR and QSPR theories. Chemom Intell Lab Syst 92:138–144CrossRefGoogle Scholar
  28. Nicholson CD, Challiss RA, Shahid M (1991) Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends Pharmacol Sci 12:19–27PubMedCrossRefGoogle Scholar
  29. Ola S, Tobias H, Egon LW, Stefan K, Martin E, Johannes W, Peter MR, Christoph S, Jarl ESW (2007) Bioclipse: an open source workbench for chemo- and bioinformatics. BMC Bioinf. doi:10.1186/1471-2105-8-59
  30. Ola S, Jonathan A, Arvid B, Martin E. Stefan K, Carl M, Gilleain T, Johannes W, Egon LW, Christoph S, Jarl ESW (2009) Bioclipse 2: a scriptable integration platform for the life sciences. BMC Bioinf. doi:10.1186/1471-2105-10-397
  31. Puurunen J, Lucke C, Schwabe U (1978) Effect of the phosphodiesterase inhibitor 4-(3-cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711) on gastric secretion and gastric mucosal cyclic AMP. Naunyn-Schmiedeberg’s Arch Pharmacol 304:69CrossRefGoogle Scholar
  32. Robinson GA, Butcher RW, Sutherland EW (1968) Cyclic AMP. Ann Rev Biochem 37:149–174CrossRefGoogle Scholar
  33. Roy K (2007) on some aspects of validations of predictive QSAR models. Expert Opin Drug Discov 2:1567–1577CrossRefGoogle Scholar
  34. Selassie D, Kapur S, Verma RP, Rosario M (2005) Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study. J Med Chem 48:7234–7242PubMedCrossRefGoogle Scholar
  35. So SS, Karplus M (1996) Evolutionary optimization in quantitative structure-activity relationship: an application of genetic neural networks. J Med Chem 39:1521–1530PubMedCrossRefGoogle Scholar
  36. Torphy TJ, Undem BJ (1991) Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax 46:512–523PubMedCrossRefGoogle Scholar
  37. Tropsha J, Gramatica P, Gombar VK (2003) The importance of being earnest: validation is the absolute essential for successful application and interpretation of QSPR models. QSAR Comb Sci 22:69–77CrossRefGoogle Scholar
  38. Wold S, Eriksson L (1995) Statistical validation of QSAR results. In: van de Waterbeemd H (ed) Chemometrics methods in molecular design. Wiley-VCH, Weinheim, pp. 309–318Google Scholar
  39. Woodrow MD, Ballantine SP, Barker MD, Clarke BJ, Dawson J, Dean TW, Delves CJ, Evans B, Gough SL, Guntrip SB, Holman S, Holmes DS, Kranz M, Lindvaal MK, Lucas FS, Neu M, Ranshaw LE, Solanke YE, Somers DO, Ward P, Wiseman JO (2009) Quinolines as a novel structural class of potent and selective PDE4 inhibitors. Optimisation for inhaled administration. Bioorg Med Chem Lett 19:5261–5265PubMedCrossRefGoogle Scholar
  40. SYBYL-X 1.2. Tripos, St. LouisGoogle Scholar
  41. VLife MDS 3.0. VLife Technologies, PuneGoogle Scholar
  42. Zeller E, Stief HJ, Pflug B, Satre Y, Herandez M (1984) Results of a phase II study of the antidepressant effect of rolipram. Pharmacopsychiatry 17:188–190PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.School of Pharmaceutical SciencesShobhit UniversityMeerutIndia

Personalised recommendations